Home > Products > CD89 & EGFR
> Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Minibody)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Minibody) (CAT#: MiniB-132)
Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Minibody) is designed to be expressed as the anti-CD89 scFv fused to N-terminus of Knob-CH3 domain and the anti-EGFR scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget macrophages to tumor cells. It is designed for the research of Head and neck cancer; Colorectal cancer (CRC); Glioblastoma multiforme (GBM); Squamous cancer; Non-small cell lung cancer (NSCLC); Solid tumors therapy.
There are currently no customer reviews or questions for Recombinant Anti-CD89 x Anti-EGFR Bispecific Antibody (Minibody) (MiniB-132). Click the button below to contact us or submit your feedback about this product.